D.A. Davidson & CO. Purchases Shares of 57,736 Perrigo Company plc (NYSE:PRGO)

D.A. Davidson & CO. purchased a new position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 57,736 shares of the company's stock, valued at approximately $1,619,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PRGO. Price T Rowe Associates Inc. MD raised its holdings in shares of Perrigo by 6,828.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,845,539 shares of the company's stock worth $201,710,000 after purchasing an additional 7,732,309 shares in the last quarter. Norges Bank purchased a new position in shares of Perrigo in the fourth quarter worth approximately $36,614,000. Ion Asset Management Ltd. raised its holdings in shares of Perrigo by 50.1% during the fourth quarter. Ion Asset Management Ltd. now owns 2,820,000 shares of the company's stock valued at $72,502,000 after acquiring an additional 941,667 shares during the period. BW Gestao de Investimentos Ltda. lifted its position in shares of Perrigo by 111.6% in the 4th quarter. BW Gestao de Investimentos Ltda. now owns 1,097,192 shares of the company's stock valued at $28,209,000 after acquiring an additional 578,597 shares in the last quarter. Finally, Boone Capital Management LLC boosted its stake in Perrigo by 126.1% in the 4th quarter. Boone Capital Management LLC now owns 1,022,369 shares of the company's stock worth $26,285,000 after purchasing an additional 570,148 shares during the period. 95.91% of the stock is currently owned by institutional investors.

Perrigo Stock Up 0.9%

Shares of PRGO stock traded up $0.25 during trading on Friday, hitting $27.52. 1,075,538 shares of the company were exchanged, compared to its average volume of 1,438,733. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.28 and a current ratio of 2.36. The firm has a market capitalization of $3.78 billion, a price-to-earnings ratio of -21.01 and a beta of 0.45. The business's 50-day simple moving average is $26.71 and its 200 day simple moving average is $26.07. Perrigo Company plc has a twelve month low of $23.14 and a twelve month high of $30.93.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.56 by $0.04. The business had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $1.09 billion. Perrigo had a negative net margin of 4.16% and a positive return on equity of 8.93%. The firm's quarterly revenue was down 3.5% compared to the same quarter last year. During the same period last year, the company posted $0.29 earnings per share. As a group, analysts forecast that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Friday, May 30th were paid a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 4.22%. The ex-dividend date was Friday, May 30th. Perrigo's dividend payout ratio (DPR) is presently -88.55%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Perrigo from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $33.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.